Filter Specialty
Filterspecialty
Submit To The Journals

EUROPEAN ENDOCRINOLOGY VOLUME 13 – ISSUE 2 – AUTUMN 2017

We are delighted to welcome you to the Autumn edition of European Endocrinology, which includes a wide selection of diabetes content to coincide with the EASD 2017.

This edition includes two articles series for you to enjoy. The first explores the development of DPP-4 inhibitors, including vildagliptin, and how the treatment landscape has evolved since research began 25 years ago. The second series focuses on continuous glucose monitoring, and evaluates how it is been adopted within the UK. Further articles on diabetic macular oedema, diabetes pathophysiology and hyperthyroidism are also included for you to enjoy.

We hope you enjoy these articles, along with the multimedia content you will find accompanying many of the articles in this edition.

Thank you to all of our contributing authors. Our Editor-in-Chief Abd Tahrani would like to welcome all members of the endocrinology community to submit articles to our Spring 2018 edition. Read our call for submissions for more information, and visit our submission system if you have a paper to submit.

Foreward

Foreword – European Endocrinology, 2017;13(2):47

Foreword – European Endocrinology, 2017;13(2):47

Letter from the Editor-in-Chief

Call for Submissions 2018

Call for Submissions 2018

Pathogenesis of Type 2 Diabetes

Beta-cell Insufficiency

Beta-cell Insufficiency

Continuous Glucose Monitoring

Is Continuous Glucose Monitoring Underappreciated in the UK?

Is Continuous Glucose Monitoring Underappreciated in the UK?

Cardiovascular Risk

Antihyperglycemic Medications and Cardiovascular Risk Reduction

Antihyperglycemic Medications and Cardiovascular Risk Reduction

Diabetic Macular Edema

Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment

Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment

Hyperthyroidism

Type 2 Diabetes Decompensation as the Clinical Presentation of Thyroid Storm – Cause or Consequence?

Type 2 Diabetes Decompensation as the Clinical Presentation of Thyroid Storm – Cause or Consequence?

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchendocrinology is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.